In Brief This Week: Luminex; Quest Diagnostics; Rosetta Genomics; Med BioGene | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex this week said that it xTAG Gastrointestinal Pathogen Panel has been CE Marked. The PCR-based panel simultaneously detects and identifies 15 parasitic, bacterial, and viral pathogens, accounting for 95 percent of all gastrointestinal infections. The test can run on the firm's Magpix and Luminex 100/200 systems.

Luminex said that it intends to file for regulatory approval of the panel in the US and Canada, but did not provide a timeline for such filings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.